Skip to content

OCT in Amblyopic Children

Analysis of Spectral Domain Optical Coherence Tomography findings in unilateral amblyopic children.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/012942
Enrollment
50
Registered
2018-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Giridhar Eye Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (a) Patients whose difference in visual acuity was at least two lines between the normal and amblyopic eye on the snellen visual acuity charts. (b) Anisometropia with an interocular difference in refraction( astigmatism >1.5 D,hypermetropia >1 D,myopia >2 D). (c) The patients with strabismic amblyopia with esotropia /exotropia/hypotropia/hypertropia of the amblyopic eye. (d) Unilateral amblyopic eyes with best corrected visual acuity of 6/12 or worse, the best corrected visual acuity of the fellow eye of 6/6.

Exclusion criteria

Exclusion criteria: Patients with (a) Ocular diseases such as glaucoma, nystagmus ,retinal disorders, or laser treatment, cataract. (b) Organic eye disease (c) Refractive errors >6 D (d) Ocular anomalies (e) Patients who were too young to cooperate (f) Patients whose pupillary dilation is not sufficient (g) Poor fixation (h) Sensory deprivation amblyopia (i) History or evidence of intraocular surgery (j) Neurological disease (k) History of seizures (l) Prematurity (birth weight (m) Mental retardation

Design outcomes

Primary

MeasureTime frame
Compare the amblyopic eye and the normal eye at the beginning and at 6 monthly after giving appropriate correction and occlusion therapy.Timepoint: 15 months at six monthly intervals.

Secondary

MeasureTime frame
Analyse the SD-OCT findings at presentation and at six months after giving appropriate correction and oclusion therapy.Timepoint: 15 months at six monthly intervals.

Countries

India

Contacts

Public ContactDR NEENA R

Giridhar Eye Institute

drlakshmisree@gmail.com9633347243

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026